Found 8 matching trials
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer NA This clinical trial is studying how well granisetron, aprepitant, and dexam...
Show More Location
Sudarshan K Sharma MD Limted-Gynecologic Oncology
Learn More & Join Trial
Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea PHASE4 The purpose of this study is to compare two different treatment protocols f...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) PHASE3 This study will compare the safety and efficacy of a three-day oral aprepit...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX PHASE2 RATIONALE: Aprepitant, palonosetron, and dexamethasone may help lessen or p...
Show More Location
St. Josephs/Cander Hospital
Learn More & Join Trial
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients NA The goal of this clinical research study is to learn the effect of combinin...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant NA RATIONALE: Antiemetic drugs, such as aprepitant, ondansetron, and dexametha...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097) PHASE3 This study is being conducted to demonstrate that aprepitant (MK-0869) prev...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) PHASE1 This study will determine the appropriate dosing regimen of aprepitant and ...
Show More Location
Multiple Locations
Learn More & Join Trial